Evaluation of cost of treatment of drug-related events in a tertiary care public sector hospital in Northern India: A prospective study

British Journal of Clinical Pharmacology

Volumn 67, Issue 3, 2009, Pages 363-369

  Pattanaik, Smita ^a   Dhamija, Punit ^a   Malhotra, Samir ^a   Sharma, Navneet ^a   Pandhi, Promila ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Drug related events; India; Public sector hospital; Treatment cost

Indexed keywords

AZATHIOPRINE; DIAZEPAM; DRUG; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; METOPROLOL; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; PYRAZINAMIDE; RIFAMPICIN; TAZOBACTAM; TRICYCLIC ANTIDEPRESSANT AGENT; WARFARIN;

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; COMPLETE HEART BLOCK; COST OF ILLNESS; DIABETIC KETOACIDOSIS; DRUG COST; DRUG INDUCED DISEASE; DRUG OVERDOSE; EMERGENCY CARE; EVALUATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COST; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTENSION; MONEY; NEUTROPENIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HOSPITAL; RASH; TERTIARY HEALTH CARE; TOXIC HEPATITIS; TREATMENT REFUSAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DRUG INTERACTIONS; EMERGENCY MEDICAL SERVICES; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INDIA; MALE; MIDDLE AGED; OVERDOSE; PATIENT COMPLIANCE; PROGRAM EVALUATION; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 62949239249     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03346.x     Document Type: Article

References (23)

1. Helper CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990 47 : 533 43.
2. Strand LM, Morley PC, Cipolle RJ, Ramsay R, Lasman GD. Drug related problems: their structure and function. Drug Intell Clin Pharm 1990 24 : 1093 7.
3. Bates DW, Miller EB, Cullen DJ, Burdick L, Williams L, Laird N, Petersen LA, Small S, Sweitzer B, Vliet MV, Leape LL. Patient risk factors for adverse drug events in hospitalized patients. Arch Intern Med 1999 159 : 2553 60.
4. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N. The cost of adverse drug events in hospitalized patients. J Am Med Assoc 1997 277 : 307 11.
5. Ayani I, Aguirre C, Gutiérrez G, Madariaga A, Rodríguez- Sasiaín JM, Martínez-Bengoechea MJ. A cost-analysis of suspected adverse drug reactions in a hospital emergency ward. Pharmacoepidemiol Drug Saf 1999 8 : 529 34.
6. White TJ, Arakelian A, Rho JP. Counting cost of drug related adverse events. Pharmacoeconomics 1999 15 : 445 58.
7. Gautier S, Bachelet H, Bordet R, Caron J. The cost of adverse drug reactions. Expert Opin Pharmacother 2003 4 : 319 26.
8. Dartnell JG, Anderson RP, Chohan V. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996 164 : 659 62.
9. Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA, Gogtay NJ. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol 2007 7 : 8.
10. Goettler M, Schneeweiss S, Hasford J. Adverse drug reaction monitoring - cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf 1997 6 (Suppl. 3 S79 90.
11. Johnson JA, Bootman JL. Drug related morbidity and mortality: a cost of illness model. Arch Intern Med 1995 155 : 1949 56.
12. Sullivan JW. A pharmaceutical manufacturer's perspective on reporting adverse drug experiences. Am J Hosp Pharm 1990 47 : 1342 5.
13. Beringer PM, Wong-Beringer A, Rho JP. Economic aspects of antibacterial adverse effects. Pharmacoeconomics 1998 13 : 35 49.
14. Lundkvist J, Jönsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol 2004 18 : 275 80.
15. World Health Organization. Intensive Drug Monitoring: the Role of National Centers. WHO technical report series No 498. Geneva : World Health Organization, 1972.
16. Col N, Fanale JE, Kronholm P. The role of medication non-compliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990 150 : 841 5.
17. Laurence DR, Bennett PN, Brown MJ. Clinical Pharmacology, 8th edn. London : Churchill Livingstone, 1997.
18. Stockly IH. Drug Ineractions, 3rd edn. Oxford : Blackwell Scientific Publications, 1994.
19. Available at http://www.economagic.com/em-cgi/data.exe/fedstl/exinus (last accessed 15 January 2008).
20. Debroy B. What is India's per capita income? Oct 15, 2005. Available at http://in.rediff.com/money/2005/oct/13income.htm (last accessed 15 January 2008).
21. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital - their severity and cost involved. Pharmacoepidemiol Drug Saf 2003 12 : 687 92.
22. Arulmani R, Rajendran SD, Suresh B. Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol 2007 65 : 210 6.
23. Malhotra S, Jain S, Pandhi P. Drug-related visits to the medical emergency department: a prospective study from India. Int J Clin Pharmacol Ther 2001 39 : 12 8.